|
PSPH expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.564800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.321800E-01 |
| Normal-vs-Stage2 |
3.617600E-01 |
| Normal-vs-Stage3 |
3.955700E-02 |
| Normal-vs-Stage4 |
3.853400E-01 |
| Stage1-vs-Stage2 |
4.377200E-01 |
| Stage1-vs-Stage3 |
8.166000E-02 |
| Stage1-vs-Stage4 |
4.060200E-01 |
| Stage2-vs-Stage3 |
5.057600E-01 |
| Stage2-vs-Stage4 |
1.610190E-01 |
| Stage3-vs-Stage4 |
3.201700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.594800E-01 |
| Normal-vs-AfricanAmerican |
6.306000E-01 |
| Normal-vs-Asian |
3.097200E-01 |
| Caucasian-vs-AfricanAmerican |
3.730000E-01 |
| Caucasian-vs-Asian |
1.472610E-01 |
| AfricanAmerican-vs-Asian |
2.490400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956190E-01 |
| Normal-vs-Female |
7.052800E-01 |
| Male-vs-Female |
2.343200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.323800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.409400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.868400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.043600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.943000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.630600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.897600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.507800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.691800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.239400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.644400E-01 |
| Normal-vs-Grade 2 |
6.693400E-01 |
| Normal-vs-Grade 3 |
7.568200E-01 |
| Normal-vs-Grade 4 |
4.909400E-01 |
| Grade 1-vs-Grade 2 |
5.085400E-01 |
| Grade 1-vs-Grade 3 |
5.727600E-01 |
| Grade 1-vs-Grade 4 |
7.698000E-01 |
| Grade 2-vs-Grade 3 |
8.700400E-01 |
| Grade 2-vs-Grade 4 |
7.601400E-01 |
| Grade 3-vs-Grade 4 |
6.284000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.773600E-01 |
| Normal-vs-ccB subtype |
4.596600E-01 |
| ccA subtype-vs-ccB subtype |
5.441400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.274400E-01 |
| Normal-vs-N1 |
2.720600E-01 |
| N0-vs-N1 |
2.221600E-01 |
|
|
